RxDoctor Payments Data

Hammam Shereef, MD

Internal Medicine · Milwaukee, WINPI 1982184156

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (37.8%), grants and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Abbott at 32.2% of the total. 2025 is the largest year on record at $23,959, more than ten times the $256 reported in 2019. Among internal medicine clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,991in general payments, 2019–2025

Across 282 payments — averaging $195.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$18K
  • Boston Scientific$14K
  • Medtronic$11K
  • Biotronik Inc.$8K
  • Biosense Webster, Inc.$3K
  • Medical Device Business Services, Inc.$917
  • plus $919 from 8 others

What the payments were for

  • Grants$20,41737%
  • Travel & lodging$20,76238%
  • Food & beverage$12,66023%
  • Education$1,1522%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,991 in reported general payments places this provider in the 95th percentile of 1,411 internal medicine providers in Wisconsin.

See all internal medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$4,020
Medicare patients
27
Services billed
36

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate23$451
Doxycycline Hyclate17$133

Paid to pharmacies, not to this prescriber.

Other internal medicine in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →